— Know what they know.
Not Investment Advice

FPMI OTC

FluoroPharma Medical, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +100.0% 3Y: +100.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 48 · $6852 mcap · 31M float · 0.0011% daily turnover · Short 84% of daily vol

Cash Flow Trends

Operating Cash Flow
-$880K +67.1% ▲
Capital Expenditures
$1K +80.7% ▲
5Y CAGR: -63.0%
Free Cash Flow
-$881K +67.2% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$266K -787.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2012FY2013FY2014FY2015FY2016
— Operating Activities —
Net Income-$4M-$6M-$4M-$3M-$2M
Depreciation & Amort.$24K$24K$42K$46K$44K
Stock-Based Comp.$545K$626K$418K$135K$32K
Change in Working Capital-$25K$153K$1M$579K$2M
Other Non-Cash Items$192K$1M-$913K-$274K-$438K
Operating Cash Flow-$3M-$3M-$3M-$3M-$880K
— Investing Activities —
Capital Expenditures-$41K-$5K-$357K-$7K-$1K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$2M$569K$36K$0
Other Investing$0$2K-$350K$36$0
Investing Cash Flow-$41K$2M$212K$29K-$1K
— Financing Activities —
Net Debt Issuance$0$275K$2M$3M$625K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$112K-$169K-$10K
Financing Cash Flow$1M$1M$2M$3M$615K
Net Change in Cash-$2M-$161K-$891K$39K-$266K
Cash End of Period$1M$1M$252K$291K$25K
Free Cash Flow-$3M-$3M-$4M-$3M-$881K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms